# Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome

> **NCT02565654** · — · UNKNOWN · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 120 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02565654
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2017-10
- **Final completion:** 2017-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2015-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02565654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02565654, "Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02565654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*